News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

immatics biotechnologies GmbH And responsif GmbH Sign A Cooperation Agreement Within The Scope Of The BioChancePLUS Grant Program



5/22/2006 2:30:07 PM

Today the biotech companies responsif GmbH and immatics biotechnologies GmbH disclosed the signing of a cooperation agreement within the scope of the BioChancePLUS grant program from the Federal Ministry of Education and Research (BMBF). The joint research project will focus on the application of technologies of both companies towards the preclinical development of a cancer vaccine.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES